CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.93%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.4B
AUM Growth
+$14.4B
(-2.7%)
Cap. Flow
-$104M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
24.27%
Holding
963
New
98
Increased
341
Reduced
352
Closed
82
Top Buys
| 1 |
ZTO Express
ZTO
|
$42.9M |
| 2 |
STKL
SunOpta
STKL
|
$39.6M |
| 3 |
Kanzhun
BZ
|
$36.9M |
| 4 |
JPMorgan Chase
JPM
|
$35M |
| 5 |
Lantheus
LNTH
|
$30.3M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$85.2M |
| 2 |
Microsoft
MSFT
|
$60.8M |
| 3 |
Veru
VERU
|
$53.9M |
| 4 |
Procter & Gamble
PG
|
$48.4M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 30.95% |
| 2 | Technology | 26.5% |
| 3 | Financials | 9.1% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Electronic Arts
EA
$42B
| $22.3M | 0.15% |
201,249
-1,043
| -0.5% | -$116K |
|
152
Tenable Holdings
TENB
$3.72B
| $22.3M | 0.15% |
509,808
| – | – |
|
153
Prologis
PLD
$103B
| $22.2M | 0.15% |
193,224
-81,966
| -30% | -$9.41M |
|
154
Toronto Dominion Bank
TD
$128B
| $22.2M | 0.15% |
402,960
-157,292
| -28% | -$8.66M |
|
155
Pinduoduo
PDD
$177B
| $21.7M | 0.15% |
310,940
+86,940
| +39% | +$6.07M |
|
156
Vipshop
VIPS
$8.36B
| $21.4M | 0.15% |
1,531,480
+1,061,630
| +226% | +$14.8M |
|
157
Netflix
NFLX
$521B
| $21.4M | 0.15% |
67,262
+1,577
| +2% | +$501K |
|
158
Fortive
FTV
$15.9B
| $21.4M | 0.15% |
340,505
+11,014
| +3% | +$691K |
|
159
Ameresco
AMRC
$1.35B
| $21.1M | 0.15% |
466,111
+192,195
| +70% | +$8.71M |
|
160
Xylem
XYL
$34B
| $21M | 0.15% |
217,433
-27,975
| -11% | -$2.7M |
|
161
Humana
HUM
$37.5B
| $20.9M | 0.14% |
46,662
-9,093
| -16% | -$4.06M |
|
|
ISEE
162
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $20.8M | 0.14% |
930,930
-204,902
| -18% | -$4.59M |
|
163
Zebra Technologies
ZBRA
$15.5B
| $20.6M | 0.14% |
70,433
+1,602
| +2% | +$469K |
|
164
Bank of Montreal
BMO
$88.5B
| $20.3M | 0.14% |
247,787
+155,075
| +167% | +$12.7M |
|
165
Bruker
BRKR
$4.45B
| $20.2M | 0.14% |
278,186
-110,000
| -28% | -$7.98M |
|
166
MongoDB
MDB
$25.5B
| $20.2M | 0.14% |
94,037
+255
| +0.3% | +$54.7K |
|
167
Edwards Lifesciences
EW
$47.7B
| $20.1M | 0.14% |
263,794
-6,281
| -2% | -$478K |
|
168
Thomson Reuters
TRI
$80B
| $19.8M | 0.14% |
159,371
-45,432
| -22% | -$5.64M |
|
|
KDNY
169
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $19.7M | 0.14% |
926,155
| – | – |
|
170
Celldex Therapeutics
CLDX
$1.57B
| $19.7M | 0.14% |
595,509
+107,000
| +22% | +$3.54M |
|
171
Boston Scientific
BSX
$159B
| $19M | 0.13% |
412,725
+16,847
| +4% | +$776K |
|
|
BPMC
172
DELISTED
Blueprint Medicines
BPMC
| $18.8M | 0.13% |
454,012
+195,701
| +76% | +$8.1M |
|
173
Relay Therapeutics
RLAY
$709M
| $18.8M | 0.13% |
1,238,872
| – | – |
|
174
Varonis Systems
VRNS
$6.21B
| $18.7M | 0.13% |
779,793
| – | – |
|
|
MORF
175
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $18.5M | 0.13% |
289,933
-55,000
| -16% | -$3.51M |
|